Skip to content
HomeLatest newsInnovation13 innovations that inspired us in 2023
A collage of four innovations from Johnson & Johnson

13 innovations that inspired us in 2023

A treatment for an incurable cancer. Catheters to better diagnose and treat AFib. A surgical stapler that’s easier to use. These are just some of the Johnson & Johnson advances that are helping improve the health of people everywhere.

Share Article
share to

Johnson & Johnson has long believed that its first responsibility is to everyone who uses its products and services—including patients, doctors and nurses, mothers and fathers. It’s a value that’s even spelled out in Our Credo, the company’s guiding mission statement.

As the year winds to a close, we’re taking a look back at advances that have helped change—or are poised to help change—the future of healthcare around the world.


Digital tags for medical devices
Unique Device Identifier code for medical devices

Efficiently tracking medical devices—like sutures and artificial knees and hips—can cut down on injuries and errors. But until recently, there was no industry-wide standard for doing so. Unique Device Identifiers (UDIs) are changing that. Johnson & Johnson is one of the first healthcare companies in the world to embed UDIs into the barcodes on the approximately 70,000 different medical devices it sells in the United States.


A suture for minimally invasive procedures
A physician wearing surgical gloves uses a STRATAFIX suture

Suturing a wound typically required surgeons to hold tissue together as they tied knots to close the wound, which can be difficult to do. Johnson & Johnson’s STRATAFIX™ sutures, however, have a series of anchors affixed to them. This helps grab the tissue to maintain tension every time a surgeon passes through tissue; it also provides a watertight seal.


A first-of-its kind intraocular lens for patients undergoing cataract surgery
Johnson & Johnson's TECNIS Eyhance™ Toric II IOL intraocular lens

The TECNIS Eyhance™ Toric II IOL (short for intraocular lens: the tiny artificial lens that replaces the eye’s natural lens when it’s removed during cataract surgery) provides the ability to clearly see images at a distance while simultaneously addressing astigmatism at the time of cataract surgery.


A new option for reverse shoulder replacement surgery
 Depuy Synthes INHANCE Shoulder system for use in reverse shoulder replacement

Last year, following clearance for its use in anatomic shoulder arthroplasty, DePuy Synthes, a Johnson & Johnson MedTech company, received clearance from the U.S. Food and Drug Administration to use its INHANCE™ Shoulder System in reverse shoulder replacements, the most common type of shoulder replacement procedures.


Ways to advance therapies and drug delivery approaches for people with bladder cancer
Female black scientist wearing blue latex gloves looking through a microscope

Johnson & Johnson has a number of clinical programs underway, which span the full spectrum of urothelial carcinoma. The goal: develop therapies that are less burdensome for all patients with bladder cancer.


AI-driven approaches to creating a healthier world
Johnson & Johnson revolutionizing AI in healthcare

Johnson & Johnson is harnessing AI (artificial intelligence) to revolutionize healthcare as we know it—from catching and diagnosing diseases earlier to diversifying clinical trials, discovering and developing new drugs and helping surgeons analyze the results of procedures.


A treatment for multiple myeloma
Multi-channel pipettes loading samples in microplates

A novel molecule discovered by a scientist at Johnson & Johnson 10 years ago was turned into a treatment for multiple myeloma that was recently approved by the U.S. Food and Drug Administration. It’s welcome news for patients with later-line relapsed refractory multiple myeloma who need additional options to help manage the incurable illness.


A surgical stapler that’s easier to use
ECHELON 3000 Stapler designed for helping surgeons to make adjustments during surgical procedures

Johnson & Johnson’s Echelon3000 makes it easier for surgeons to maneuver in tight spaces with more precision. It was designed to be used in a number of minimally invasive procedures—including thoracic, colorectal and bariatric surgeries—by a variety of surgeons, all of whom have different hand sizes and preferences.


Super-personalized solutions to healthcare challenges
 Pipette adding sample to petri dish for medical research

Johnson & Johnson scientists are using precision medicine technology to develop and refine novel treatments for diseases of the cardiovascular system, immune system and neurological system, as well as for pulmonary hypertension, infectious diseases, oncology and more.


A possible way to catch Alzheimer’s before it starts
Alzheimer's brain scans

Scientists at Johnson & Johnson have developed an investigational sensitive blood test that measures one of the earliest biomarkers that change in people with Alzheimer’s. The goal of this blood test is to identify the disease in patients at a much earlier stage; researchers hope to start clinical trials soon. Data scientists and digital health experts at the company are also developing ways to use AI and augmented reality (AR) to identify people who are at the very earliest stages of cognitive decline.


A technology platform that helps surgeons see clearly during spinal operations
 The Teligen system, a surgical technology platform that helps surgeons see clearly during spinal surgery

With the Teligen™ System, a disposable camera the size of a pinkie finger goes inside a tube and can be slid up and down and rotated in all directions, offering multidirectional and enhanced visualization during back procedures.


Catheters that help diagnose and treat atrial fibrillation
A doctor holding a catheter for AFib

Among the newest innovations for AFib (short for atrial fibrillation, a type of arrhythmia or abnormal heartbeat) are two catheters developed by Biosense Webster, a Johnson & Johnson MedTech company.


Technologies that help advance the treatment of ischemic stroke
Imaging of stroke

Stroke Solutions™, a suite of technologies launched by Cerenovus, Inc., part of Johnson & Johnson MedTech, makes it easier and quicker for doctors to reach and remove blood clots in people who’ve experienced an ischemic stroke, the most common type of stroke.

More from Johnson & Johnson

By the numbers: Understanding dry eye disease

For National Dry Eye Awareness Month, learn about the causes of this common condition and how Johnson & Johnson is helping to find treatment options.

What to know about We All Belong: 2023 DEI Impact Review

The annual report details how Johnson & Johnson is harnessing the power of diversity, equity and inclusion to provide better care around the world.
You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.